Delivery Order SPE2DB22D3004-SPE2DB25FSA08
- Not listed
- The Defense Logistics Agency awarded a $15,808.62 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. The contract was executed on August 13, 2025, with an ultimate completion date of August 14, 2025, and carries firm fixed pricing under a non-set-aside competitive award. Performance of the contract is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a $22,144.15 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a pharmaceutical product commonly used for anticoagulation therapy. The award was made on September 3, 2025, with an ultimate completion date of September 4, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded under open procurement procedures. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg, a widely prescribed anticoagulant medication. The contract, awarded on August 22, 2025, with an ultimate completion date of August 25, 2025, is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $11,944.06 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. Awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, this firm fixed-price contract represents a competitively awarded, non-set-aside delivery order. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $14,787.00. This firm fixed-price delivery order, which is set to be completed by August 12, 2025, will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award represents a competitive procurement with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet...
- The Defense Logistics Agency awarded a $23,088.53 delivery order to AmerisourceBergen Drug Corp for 60-count tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. The contract, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. Performance will be conducted at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $13,452.67. This firm fixed-price delivery order is scheduled for completion by July 21, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order issued without set-aside restrictions, drawing from AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $11,516.50 to supply 60 tablets of Eliquis 5 mg, a widely-used anticoagulant medication. Issued on August 7, 2025, with an ultimate completion date of August 8, 2025, this firm fixed-price delivery order represents a routine pharmaceutical procurement within the federal medical supply chain. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will be executed...
- The Defense Logistics Agency (DLA) awarded a $9,868.31 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. This competitive delivery order, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, carries firm fixed pricing and represents a child contract under AmerisourceBergen's broader pharmaceutical supply vehicle with DLA. The place of performance is AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $1,591.08 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packaging) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing contract...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSA08Delivery Order
The Defense Logistics Agency awarded a $2,248.92 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. This contract represents a firm fixed-price delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania facility, and is scheduled for completion by August 15, 2025. The award reflects DLA's procurement of pharmaceutical products to support federal healthcare operations, including military medical supply chains. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp maintains an extensive portfolio supplying brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains to military healthcare systems and other government agencies. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling flexible fulfillment of federal medical supply needs through competitively awarded delivery orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 8/14/25 |